Global Blood Therapeutics, Inc.
(NASDAQ : GBT)

( )
GBT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -2.66%567.042.7%$651.45m
GILDGilead Sciences, Inc. -2.15%58.721.0%$577.62m
AMGNAmgen, Inc. -3.17%216.381.3%$567.02m
VRTXVertex Pharmaceuticals, Inc. -1.81%208.341.9%$534.17m
MRNAModerna, Inc. -6.98%65.740.0%$415.50m
ILMNIllumina, Inc. -3.75%309.693.5%$397.23m
EXASEXACT Sciences Corp. -2.75%127.5220.7%$297.60m
ALXNAlexion Pharmaceuticals, Inc. -4.29%114.852.0%$259.81m
BIIBBiogen, Inc. -4.32%244.261.7%$251.09m
NVAXNovavax, Inc. -9.22%81.3396.5%$238.36m
BNTXBioNTech SE -7.64%77.540.0%$198.15m
SRRKScholar Rock Holding Corp. 44.67%43.430.0%$174.98m
SGENSeagen Inc. -1.05%194.856.0%$144.96m
SRNESorrento Therapeutics, Inc. -8.04%7.091.4%$135.51m
CRSPCRISPR Therapeutics AG -3.48%94.710.6%$123.39m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.